Norman K. Hollenberg focuses on Internal medicine, Endocrinology, Angiotensin II, Renal blood flow and Renin–angiotensin system. Norman K. Hollenberg works mostly in the field of Internal medicine, limiting it down to topics relating to Cardiology and, in certain cases, Pathology. Endocrinology and Enzyme inhibitor are commonly linked in his work.
His Angiotensin II study incorporates themes from Nephropathy, Angiotensin-converting enzyme, Vascular smooth muscle and Captopril. The study incorporates disciplines such as Vasoconstriction, Natriuresis, Renal physiology and Renal artery in addition to Renal blood flow. His Renin–angiotensin system study combines topics from a wide range of disciplines, such as Salt intake and Pharmacology.
Norman K. Hollenberg mainly investigates Internal medicine, Endocrinology, Renin–angiotensin system, Angiotensin II and Kidney. The Internal medicine study which covers Cardiology that intersects with Surgery. His Endocrinology study is mostly concerned with Aldosterone, Angiotensin-converting enzyme, Captopril, Renal circulation and Renal function.
His biological study spans a wide range of topics, including Diabetes mellitus, Blockade, Pharmacology and Enzyme inhibitor. His Angiotensin II study frequently draws connections between adjacent fields such as ACE inhibitor. His Renal blood flow research incorporates themes from Vasoconstriction and Renal artery.
His main research concerns Internal medicine, Endocrinology, Renin–angiotensin system, Diabetes mellitus and Blood pressure. The Internal medicine study combines topics in areas such as Nephropathy and Cardiology. His research related to Renal blood flow, Angiotensin II, Plasma renin activity, Captopril and Diabetic nephropathy might be considered part of Endocrinology.
His Renin–angiotensin system study incorporates themes from Blockade, Angiotensin-converting enzyme, Pharmacology and Enzyme inhibitor. His Diabetes mellitus research is multidisciplinary, relying on both Surgery, Endothelial dysfunction and Intensive care medicine. His Kidney research focuses on Essential hypertension and how it relates to Aldosterone.
Internal medicine, Endocrinology, Blood pressure, Kidney and Renin–angiotensin system are his primary areas of study. His Internal medicine research is multidisciplinary, incorporating elements of Diabetes mellitus, Urology and Cardiology. Renal function, Angiotensin II, Plasma renin activity, Aliskiren and Nephropathy are among the areas of Endocrinology where the researcher is concentrating his efforts.
Norman K. Hollenberg combines subjects such as Hemodynamics, Cardiovascular health, Compliance and Pediatrics with his study of Blood pressure. Kidney is a component of his Renal blood flow and Tubuloglomerular feedback studies. His study focuses on the intersection of Renin–angiotensin system and fields such as Enzyme inhibitor with connections in the field of Renin inhibitor and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Hans-Henrik Parving;Frederik Persson;Julia B. Lewis;Edmund J. Lewis.
The New England Journal of Medicine (2008)
(–)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans
Hagen Schroeter;Christian Heiss;Christian Heiss;Jan Balzer;Petra Kleinbongard.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.
V J Dzau;W S Colucci;N K Hollenberg;G H Williams.
Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans
Naomi D L Fisher;Meghan Hughes;Marie Gerhard-Herman;Norman K Hollenberg.
Journal of Hypertension (2003)
Discontinuation of antihyperlipidemic drugs : do rates reported in clinical trials reflect rates in primary care settings ?
Susan E. Andrade;Alexander M. Walker;Lawrence K. Gottlieb;Norman K. Hollenberg.
The New England Journal of Medicine (1995)
Renal failure in the patient with cirrhosis: The role of active vasoconstriction
Murray Epstein;Dennis P. Berk;Norman K. Hollenberg;Douglass F. Adams.
The American Journal of Medicine (1970)
Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia.
Victor J. Dzau;Milton Packer;Leonard S. Lilly;Stephen L. Swartz.
The New England Journal of Medicine (1984)
Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure
Victor J. Dzau;Wilson S. Colucci;Gordon H. Williams;Gregory Curfman.
The New England Journal of Medicine (1980)
Cocoa and cardiovascular health.
Roberto Corti;Andreas J. Flammer;Norman K. Hollenberg;Thomas F. Lüscher.
Pathways for Angiotensin II Generation in Intact Human Tissue Evidence From Comparative Pharmacological Interruption of the Renin System
Norman K. Hollenberg;Naomi D. L. Fisher;Deborah A. Price.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: